{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:47:35Z","timestamp":1765295255910,"version":"3.41.2"},"reference-count":114,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:00:00Z","timestamp":1627516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Anti-myeloperoxidase vasculitis (MPO-AAV) is a life-threatening autoimmune disease which causes severe inflammation of small blood vessels, mainly in the kidney. As for many other autoimmune diseases, current treatments, which consist of general immunosuppressants, are partially effective, toxic and broadly immunosuppressive, causing significant and serious adverse effects in many patients. Therefore, there is an urgent need for more targeted and less harmful therapies. Tolerogenic dendritic cells, regulatory T cells and stem cells have emerged as attractive, new and safer options for the treatment for various autoimmune diseases due to their unique and selective immunosuppressive capacity. In this review, we will discuss how these cellular therapies offer potential to become novel and safer treatments for MPO-AAV.<\/jats:p>","DOI":"10.3389\/fimmu.2021.642127","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T09:28:26Z","timestamp":1627550906000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Emerging Cellular Therapies for Anti-myeloperoxidase Vasculitis and Other Autoimmune Diseases"],"prefix":"10.3389","volume":"12","author":[{"given":"Dragana","family":"Odobasic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen R.","family":"Holdsworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014090903","article-title":"Proteinase 3-ANCA Vasculitis Versus Myeloperoxidase-ANCA Vasculitis","volume":"26","author":"Hilhorst","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-013-0830-8","article-title":"Epidemiology and Clinical Features of Systemic Vasculitis","volume":"17","author":"Scott","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2014.104","article-title":"Key Advances in the Clinical Approach to ANCA-Associated Vasculitis","volume":"10","author":"Kallenberg","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.108043","article-title":"Genetically Distinct Subsets Within ANCA-Associated Vasculitis","volume":"367","author":"Lyons","year":"2012","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e28626","DOI":"10.1371\/journal.pone.0028626","article-title":"Anti-Proteinase 3 Anti-Neutrophil Cytoplasm Autoantibodies Recapitulate Systemic Vasculitis in Mice With a Humanized Immune System","volume":"7","author":"Little","year":"2012","journal-title":"PLoS One"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.064626","article-title":"Rats and Mice Immunised With Chimeric Human\/Mouse Proteinase 3 Produce Autoantibodies to Mouse Pr3 and Rat Granulocytes","volume":"66","author":"van der Geld","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2013.08.025","article-title":"Histopathologic and Clinical Predictors of Kidney Outcomes in ANCA-Associated Vasculitis","volume":"63","author":"Ford","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"B8","doi-asserted-by":"publisher","first-page":"2349817","DOI":"10.1155\/2016\/2349817","article-title":"Neutrophil-Mediated Regulation of Innate and Adaptive Immunity: The Role of Myeloperoxidase","volume":"2016","author":"Odobasic","year":"2016","journal-title":"J Immunol Res"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2012.04616.x","article-title":"Animal Models of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis","volume":"169","author":"Coughlan","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1681\/ASN.V103499","article-title":"Prominence of Cell-Mediated Immunity Effectors in \u201cPauci-Immune\u201d Glomerulonephritis","volume":"10","author":"Cunningham","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2013.04.007","article-title":"Myeloperoxidase (MPO)-Specific CD4+ T Cells Contribute to MPO-Anti-Neutrophil Cytoplasmic Antibody (ANCA) Associated Glomerulonephritis","volume":"282","author":"Gan","year":"2013","journal-title":"Cell Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.2012.04615.x","article-title":"How Anti-Neutrophil Cytoplasmic Autoantibodies Activate Neutrophils","volume":"169","author":"Kettritz","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2006020108","article-title":"Anti-Neutrophil Cytoplasmic Antibodies and Effector CD4+ Cells Play Nonredundant Roles in Anti-Myeloperoxidase Crescentic Glomerulonephritis","volume":"17","author":"Ruth","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI0215918","article-title":"Antineutrophil Cytoplasmic Autoantibodies Specific for Myeloperoxidase Cause Glomerulonephritis and Vasculitis in Mice","volume":"110","author":"Xiao","year":"2002","journal-title":"J Clin Invest"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200104)44:4<921::AID-ANR149>3.0.CO;2-4","article-title":"IgG From Myeloperoxidase-Antineutrophil Cytoplasmic Antibody-Positive Patients Stimulates Greater Activation of Primed Neutrophils Than IgG From Proteinase 3-Antineutrophil Cytosplasmic Antibody-Positive Patients","volume":"44","author":"Harper","year":"2001","journal-title":"Arthritis Rheum"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1210147109","article-title":"The Immunodominant Myeloperoxidase T-Cell Epitope Induces Local Cell-Mediated Injury in Antimyeloperoxidase Glomerulonephritis","volume":"109","author":"Ooi","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00525","article-title":"Animal Models of ANCA Associated Vasculitis","volume":"11","author":"Shochet","year":"2020","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012060572","article-title":"Mast Cells Contribute to Peripheral Tolerance and Attenuate Autoimmune Vasculitis","volume":"23","author":"Gan","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2009070763","article-title":"Th17 Cells Promote Autoimmune Anti-Myeloperoxidase Glomerulonephritis","volume":"21","author":"Gan","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1172\/JCI65292","article-title":"Epitope Specificity Determines Pathogenicity and Detectability in ANCA-Associated Vasculitis","volume":"123","author":"Roth","year":"2013","journal-title":"J Clin Invest"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1038\/s41467-019-11255-0","article-title":"A Plasmid-Encoded Peptide From Staphylococcus Aureus Induces Anti-Myeloperoxidase Nephritogenic Autoimmunity","volume":"10","author":"Ooi","year":"2019","journal-title":"Nat Commun"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2015.202","article-title":"Renal Participation of Myeloperoxidase in Antineutrophil Cytoplasmic Antibody (ANCA)-Associated Glomerulonephritis","volume":"88","author":"O\u2019Sullivan","year":"2015","journal-title":"Kidney Int"},{"key":"B23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1681\/ASN.2015121356","article-title":"CD8+ T Cells Effect Glomerular Injury in Experimental Anti-Myeloperoxidase GN","volume":"28","author":"Chang","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2017.05.003","article-title":"Monocytes Promote Crescent Formation in Anti-Myeloperoxidase Antibody-Induced Glomerulonephritis","volume":"187","author":"Rousselle","year":"2017","journal-title":"Am J Pathol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp783","article-title":"Serum IL-17 and IL-23 Levels and Autoantigen-Specific Th17 Cells are Elevated in Patients With ANCA-Associated Vasculitis","volume":"25","author":"Nogueira","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/art.30208","article-title":"Toll-Like Receptor 2 Induces Th17 Myeloperoxidase Autoimmunity While Toll-Like Receptor 9 Drives Th1 Autoimmunity in Murine Vasculitis","volume":"63","author":"Summers","year":"2011","journal-title":"Arthritis Rheum"},{"key":"B27","article-title":"In Vitro Production of Myeloperoxidase Anti-Neutrophil Cytoplasmic Antibody and Establishment of Th1-Type T Cell Lines From Peripheral Blood Lymphocytes of Patients","volume":"23","author":"Yoshida","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/art.37959","article-title":"Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Have Defective Treg Cell Function Exacerbated by the Presence of a Suppression-Resistant Effector Cell Population","volume":"65","author":"Free","year":"2013","journal-title":"Arthritis Rheum"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2012090898","article-title":"Thymic Deletion and Regulatory T Cells Prevent Antimyeloperoxidase GN","volume":"24","author":"Tan","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.12.002","article-title":"Cellular Immune Regulation in the Pathogenesis of ANCA-Associated Vasculitides","volume":"17","author":"von Borstel","year":"2018","journal-title":"Autoimmun Rev"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.137778","article-title":"Long-Term Patient Survival in ANCA-Associated Vasculitis","volume":"70","author":"Flossmann","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s40674-017-0082-y","article-title":"Avoidance of Harm From Treatment for ANCA-Associated Vasculitis","volume":"3","author":"King","year":"2017","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-017-3855-6","article-title":"Patient Perceptions of Glucocorticoids in Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis","volume":"38","author":"Robson","year":"2018","journal-title":"Rheumatol Int"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016111179","article-title":"Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis","volume":"28","author":"Jayne","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa2023386","article-title":"Avacopan for the Treatment of ANCA-Associated Vasculitis","volume":"384","author":"Jayne","year":"2021","journal-title":"N Engl J Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206404","article-title":"Rituximab Versus Cyclophosphamide in ANCA-Associated Renal Vasculitis: 2-Year Results of a Randomised Trial","volume":"74","author":"Jones","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00350","article-title":"Mechanisms of Tolerance Induction by Dendritic Cells In Vivo","volume":"9","author":"Hasegawa","year":"2018","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20082394","article-title":"Constitutive Ablation of Dendritic Cells Breaks Self-Tolerance of CD4 T Cells and Results in Spontaneous Fatal Autoimmunity","volume":"206","author":"Ohnmacht","year":"2009","journal-title":"J Exp Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00894","article-title":"Co-Stimulation-Impaired Bone Marrow-Derived Dendritic Cells Prevent Dextran Sodium Sulfate-Induced Colitis in Mice","volume":"9","author":"Engman","year":"2018","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.159.10.4772","article-title":"Induction of Tolerance by IL-10-Treated Dendritic Cells","volume":"159","author":"Steinbrink","year":"1997","journal-title":"J Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/art.22655","article-title":"Antigen-Specific Suppression of Established Arthritis in Mice by Dendritic Cells Deficient in NF-kappaB","volume":"56","author":"Martin","year":"2007","journal-title":"Arthritis Rheum"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1002\/art.27756","article-title":"Therapeutic Effect of Tolerogenic Dendritic Cells in Established Collagen-Induced Arthritis is Associated With a Reduction in Th17 Responses","volume":"62","author":"Stoop","year":"2010","journal-title":"Arthritis Rheum"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302350","article-title":"1,25-Dihydroxyvitamin D3 Promotes Tolerogenic Dendritic Cells With Functional Migratory Properties in NOD Mice","volume":"192","author":"Ferreira","year":"2014","journal-title":"J Immunol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(02)00503-4","article-title":"Antigen-Specific Suppression of a Primed Immune Response by Dendritic Cells Mediated by Regulatory T Cells Secreting Interleukin-10","volume":"18","author":"Martin","year":"2003","journal-title":"Immunity"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2011.03.003","article-title":"IL-10-Conditioned Dendritic Cells Prevent Autoimmune Diabetes in NOD and Humanized HLA-DQ8\/RIP-B7.1 Mice","volume":"139","author":"Tai","year":"2011","journal-title":"Clin Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.2337\/db12-1740","article-title":"Protection of Islet Grafts Through Transforming Growth Factor-Beta-Induced Tolerogenic Dendritic Cells","volume":"62","author":"Thomas","year":"2013","journal-title":"Diabetes"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.425751","article-title":"Fas Signal Promotes the Immunosuppressive Function of Regulatory Dendritic Cells via the ERK\/beta-Catenin Pathway","volume":"288","author":"Qian","year":"2013","journal-title":"J Biol Chem"},{"key":"B48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1124\/jpet.106.103259","article-title":"Inhibition of Nuclear Factor-Kappa B Enhances the Capacity of Immature Dendritic Cells to Induce Antigen-Specific Tolerance in Experimental Autoimmune Encephalomyelitis","volume":"318","author":"Iruretagoyena","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.8.1976","article-title":"Prevention of Diabetes in NOD Mice by Administration of Dendritic Cells Deficient in Nuclear Transcription factor-kappaB Activity","volume":"52","author":"Ma","year":"2003","journal-title":"Diabetes"},{"key":"B50","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.jaci.2009.11.042","article-title":"A Novel Allergen-Specific Therapy for Allergy Using CD40-Silenced Dendritic Cells","volume":"125","author":"Suzuki","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14182","article-title":"Renal Allograft Survival in Nonhuman Primates Infused With Donor Antigen-Pulsed Autologous Regulatory Dendritic Cells","volume":"17","author":"Ezzelarab","year":"2017","journal-title":"Am J Transplant"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.7.4331","article-title":"Antisense Oligonucleotides Down-Regulating Costimulation Confer Diabetes-Preventive Properties to Nonobese Diabetic Mouse Dendritic Cells","volume":"173","author":"Machen","year":"2004","journal-title":"J Immunol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"290ra87","DOI":"10.1126\/scitranslmed.aaa9301","article-title":"Citrullinated Peptide Dendritic Cell Immunotherapy in HLA Risk Genotype-Positive Rheumatoid Arthritis Patients","volume":"7","author":"Benham","year":"2015","journal-title":"Sci Transl Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-0472","article-title":"Phase I (Safety) Study of Autologous Tolerogenic Dendritic Cells in Type 1 Diabetic Patients","volume":"34","author":"Giannoukakis","year":"2011","journal-title":"Diabetes Care"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv144","article-title":"Intraperitoneal Administration of Autologous Tolerogenic Dendritic Cells for Refractory Crohn\u2019s Disease: A Phase I Study","volume":"9","author":"Jauregui-Amezaga","year":"2015","journal-title":"J Crohns Colitis"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208456","article-title":"Autologous Tolerogenic Dendritic Cells for Rheumatoid and Inflammatory Arthritis","volume":"76","author":"Bell","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1820039116","article-title":"Immune Tolerance in Multiple Sclerosis and Neuromyelitis Optica With Peptide-Loaded Tolerogenic Dendritic Cells in a Phase 1b Trial","volume":"116","author":"Zubizarreta","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2019030236","article-title":"Tolerogenic Dendritic Cells Attenuate Experimental Autoimmune Antimyeloperoxidase Glomerulonephritis","volume":"30","author":"Odobasic","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/nature05479","article-title":"Regulatory T-Cell Functions are Subverted and Converted Owing to Attenuated Foxp3 Expression","volume":"445","author":"Wan","year":"2007","journal-title":"Nature"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e18734","DOI":"10.1371\/journal.pone.0018734","article-title":"Decreased Numbers of Blood Dendritic Cells and Defective Function of Regulatory T Cells in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis","volume":"6","author":"Rimbert","year":"2011","journal-title":"PLoS One"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-03-492397","article-title":"Human Regulatory T Cells Against Minor Histocompatibility Antigens: Ex Vivo Expansion for Prevention of Graft-Versus-Host Disease","volume":"122","author":"Veerapathran","year":"2013","journal-title":"Blood"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T Cells: Mechanisms of Differentiation and Function","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101638","article-title":"Transfer of Regulatory Properties From Tolerogenic to Proinflammatory Dendritic Cells via Induced Autoreactive Regulatory T Cells","volume":"187","author":"Kleijwegt","year":"2011","journal-title":"J Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"7015","DOI":"10.3390\/ijms21197015","article-title":"Treg Enhancing Therapies to Treat Autoimmune Diseases","volume":"21","author":"Eggenhuizen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.1.154","article-title":"Interaction of TNF With TNF Receptor Type 2 Promotes Expansion and Function of Mouse CD4+CD25+ T Regulatory Cells","volume":"179","author":"Chen","year":"2007","journal-title":"J Immunol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1084\/jem.192.2.295","article-title":"Cytotoxic T Lymphocyte-Associated Antigen 4 Plays an Essential Role in the Function of CD25(+)CD4(+) Regulatory Cells That Control Intestinal Inflammation","volume":"192","author":"Read","year":"2000","journal-title":"J Exp Med"},{"key":"B67","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nm1688","article-title":"Prevention of Acute and Chronic Allograft Rejection With CD4+CD25+Foxp3+ Regulatory T Lymphocytes","volume":"14","author":"Joffre","year":"2008","journal-title":"Nat Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20040139","article-title":"In Vitro-Expanded Antigen-Specific Regulatory T Cells Suppress Autoimmune Diabetes","volume":"199","author":"Tang","year":"2004","journal-title":"J Exp Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1742-2094-9-112","article-title":"CAR\/FoxP3-Engineered T Regulatory Cells Target the CNS and Suppress EAE Upon Intranasal Delivery","volume":"9","author":"Fransson","year":"2012","journal-title":"J Neuroinflamm"},{"key":"B70","doi-asserted-by":"publisher","first-page":"315ra189","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 Diabetes Immunotherapy Using Polyclonal Regulatory T Cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci Transl Med"},{"key":"B71","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clim.2014.03.016","article-title":"Therapy of Type 1 Diabetes With CD4(+)CD25(high)CD127-Regulatory T Cells Prolongs Survival of Pancreatic Islets - Results of One Year Follow-Up","volume":"153","author":"Marek-Trzonkowska","year":"2014","journal-title":"Clin Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/nature22329","article-title":"Dominant Protection From HLA-Linked Autoimmunity by Antigen-Specific Regulatory T Cells","volume":"545","author":"Ooi","year":"2017","journal-title":"Nature"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200838904","article-title":"Loss of FOXP3 Expression in Natural Human CD4+CD25+ Regulatory T Cells Upon Repetitive In Vitro Stimulation","volume":"39","author":"Hoffmann","year":"2009","journal-title":"Eur J Immunol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"102306","DOI":"10.1016\/j.jaut.2019.102306","article-title":"Restricted Myeloperoxidase Epitopes Drive the Adaptive Immune Response in MPO-ANCA Vasculitis","volume":"106","author":"Free","year":"2020","journal-title":"J Autoimmun"},{"key":"B75","doi-asserted-by":"publisher","first-page":"e0192952","DOI":"10.1371\/journal.pone.0192952","article-title":"A Myeloperoxidase Precursor, Pro-Myeloperoxidase, is Present in Human Plasma and Elevated in Cardiovascular Disease Patients","volume":"13","author":"Khalilova","year":"2018","journal-title":"PLoS One"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1111\/j.0105-2896.2006.00422.x","article-title":"Dendritic Cells Expand Antigen-Specific Foxp3+ CD25+ CD4+ Regulatory T Cells Including Suppressors of Alloreactivity","volume":"212","author":"Yamazaki","year":"2006","journal-title":"Immunol Rev"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2010.03199.x","article-title":"Rapamycin-Conditioned Donor Dendritic Cells Differentiate CD4CD25Foxp3 T Cells In Vitro With TGF-Beta1 for Islet Transplantation","volume":"10","author":"Pothoven","year":"2010","journal-title":"Am J Transplant"},{"key":"B78","doi-asserted-by":"publisher","first-page":"7573154","DOI":"10.1155\/2017\/7573154","article-title":"Adoptive Cell Therapy of Induced Regulatory T Cells Expanded by Tolerogenic Dendritic Cells on Murine Autoimmune Arthritis","volume":"2017","author":"Yang","year":"2017","journal-title":"J Immunol Res"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.4252\/wjsc.v11.i4.212","article-title":"Issues and Opportunities of Stem Cell Therapy in Autoimmune Diseases","volume":"11","author":"Muzes","year":"2019","journal-title":"World J Stem Cells"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1634\/stemcells.2004-0357","article-title":"Stem Cell Characteristics of Amniotic Epithelial Cells","volume":"23","author":"Miki","year":"2005","journal-title":"Stem Cells"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2012.00066","article-title":"Post-Stroke Inflammation and the Potential Efficacy of Novel Stem Cell Therapies: Focus on Amnion Epithelial Cells","volume":"6","author":"Broughton","year":"2012","journal-title":"Front Cell Neurosci"},{"key":"B82","doi-asserted-by":"publisher","first-page":"Unit 1E 6","DOI":"10.1002\/9780470151808.sc01e06s13","article-title":"Amnion Epithelial Cell Isolation and Characterization for Clinical Use","author":"Murphy","year":"2010","journal-title":"Curr Protoc Stem Cell Biol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201001-0014OC","article-title":"Human Amnion Epithelial Cell Transplantation Abrogates Lung Fibrosis and Augments Repair","volume":"182","author":"Moodley","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"B84","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ajo.2005.09.008","article-title":"Ocular Surface Restoration Using non-Surgical Transplantation of Tissue-Cultured Human Amniotic Epithelial Cells","volume":"141","author":"Parmar","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00007.2005","article-title":"Administered Mesenchymal Stem Cells Protect Against Ischemic Acute Renal Failure Through Differentiation-Independent Mechanisms","volume":"289","author":"Togel","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3002","article-title":"Plasticity of Mesenchymal Stem Cells in Immunomodulation: Pathological and Therapeutic Implications","volume":"15","author":"Wang","year":"2014","journal-title":"Nat Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.04-0495","article-title":"Immunosuppressive Factors Secreted by Human Amniotic Epithelial Cells","volume":"46","author":"Li","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.17-0185","article-title":"Amnion Epithelial Cell-Derived Exosomes Restrict Lung Injury and Enhance Endogenous Lung Repair","volume":"7","author":"Tan","year":"2018","journal-title":"Stem Cells Transl Med"},{"key":"B89","doi-asserted-by":"publisher","first-page":"e35758","DOI":"10.1371\/journal.pone.0035758","article-title":"Amniotic Epithelial Cells From the Human Placenta Potently Suppress a Mouse Model of Multiple Sclerosis","volume":"7","author":"Liu","year":"2012","journal-title":"PLoS One"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.3727\/096368910X504496","article-title":"Transplantation of Human Amnion Epithelial Cells Reduces Hepatic Fibrosis in Immunocompetent CCl(4)-Treated Mice","volume":"19","author":"Manuelpillai","year":"2010","journal-title":"Cell Transplant"},{"key":"B91","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/scrt542","article-title":"Amnion Cell Mediated Immune Modulation Following Bleomycin Challenge: Controlling the Regulatory T Cell Response","volume":"6","author":"Tan","year":"2015","journal-title":"Stem Cell Res Ther"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3727\/096368912X661409","article-title":"Human Amnion Epithelial Cells Mediate Lung Repair by Directly Modulating Macrophage Recruitment and Polarization","volume":"23","author":"Tan","year":"2014","journal-title":"Cell Transplant"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1177\/0963689718796196","article-title":"Subretinal Transplantation of Human Amniotic Epithelial Cells in the Treatment of Autoimmune Uveitis in Rats","volume":"27","author":"Li","year":"2018","journal-title":"Cell Transplant"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2018.04.001","article-title":"Therapeutic Effect of Human Amniotic Epithelial Cells in Murine Models of Hashimoto\u2019s Thyroiditis and Systemic Lupus Erythematosus","volume":"20","author":"Tan","year":"2018","journal-title":"Cytotherapy"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.117.019136","article-title":"Acute or Delayed Systemic Administration of Human Amnion Epithelial Cells Improves Outcomes in Experimental Stroke","volume":"49","author":"Evans","year":"2018","journal-title":"Stroke"},{"key":"B96","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.placenta.2018.06.008","article-title":"Immunomodulatory Effects of Human Amniotic Epithelial Cells on Naive CD4(+) T Cells From Women With Unexplained Recurrent Spontaneous Abortion","volume":"71","author":"Motedayyen","year":"2018","journal-title":"Placenta"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1089\/ten.2006.0313","article-title":"Dose-Dependent Immunomodulatory Effect of Human Stem Cells From Amniotic Membrane: A Comparison With Human Mesenchymal Stem Cells From Adipose Tissue","volume":"13","author":"Wolbank","year":"2007","journal-title":"Tissue Eng"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/j.placenta.2013.03.010","article-title":"Preterm Human Amnion Epithelial Cells Have Limited Reparative Potential","volume":"34","author":"Lim","year":"2013","journal-title":"Placenta"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1221535110","article-title":"Exocytosis Acts as a Modulator of the ILT4-Mediated Inhibition of Neutrophil Functions","volume":"110","author":"Baudhuin","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00592","article-title":"HLA-G Molecules in Autoimmune Diseases and Infections","volume":"5","author":"Rizzo","year":"2014","journal-title":"Front Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00748","article-title":"The Human Amnion Epithelial Cell Secretome Decreases Hepatic Fibrosis in Mice With Chronic Liver Fibrosis","volume":"8","author":"Alhomrani","year":"2017","journal-title":"Front Pharmacol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00518","article-title":"Immunotherapeutic Potential of Extracellular Vesicles","volume":"5","author":"Zhang","year":"2014","journal-title":"Front Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.114173","article-title":"Exosomes Mediate the Cytoprotective Action of Mesenchymal Stromal Cells on Hypoxia-Induced Pulmonary Hypertension","volume":"126","author":"Lee","year":"2012","journal-title":"Circulation"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfr015","article-title":"Microvesicles Derived From Human Adult Mesenchymal Stem Cells Protect Against Ischaemia-Reperfusion-Induced Acute and Chronic Kidney Injury","volume":"26","author":"Gatti","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1111\/aji.12662","article-title":"Molecular Displaying of Differential Immunoresponse to Various Infections of Amniotic Epithelia","volume":"77","author":"Nemr","year":"2017","journal-title":"Am J Reprod Immunol"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1248\/bpb.25.239","article-title":"Differential mRNA Expression of Inflammatory Cytokines in Cultured Human Fetal Membrane Cells Responding to Influenza Virus Infection","volume":"25","author":"Uchide","year":"2002","journal-title":"Biol Pharm Bull"},{"key":"B107","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jcyt.2013.07.005","article-title":"Human Amniotic Epithelial Cells Induce Apoptosis of Cancer Cells: A New Anti-Tumor Therapeutic Strategy","volume":"16","author":"Niknejad","year":"2014","journal-title":"Cytotherapy"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.31159","article-title":"Vaccination With Human Amniotic Epithelial Cells Confer Effective Protection in a Murine Model of Colon Adenocarcinoma","volume":"142","author":"Tabatabaei","year":"2018","journal-title":"Int J Cancer"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3727\/096368912X653039","article-title":"In Vivo Differentiation of Human Amniotic Epithelial Cells Into Cardiomyocyte-Like Cells and Cell Transplantation Effect on Myocardial Infarction in Rats: Comparison With Cord Blood and Adipose Tissue-Derived Mesenchymal Stem Cells","volume":"21","author":"Fang","year":"2012","journal-title":"Cell Transplant"},{"key":"B110","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s10561-017-9618-5","article-title":"Amniotic Membrane in Ophthalmology: Properties, Preparation, Storage and Indications for Grafting-a Review","volume":"18","author":"Jirsova","year":"2017","journal-title":"Cell Tissue Bank"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.18-0079","article-title":"First-In-Human Administration of Allogeneic Amnion Cells in Premature Infants With Bronchopulmonary Dysplasia: A Safety Study","volume":"7","author":"Lim","year":"2018","journal-title":"Stem Cells Transl Med"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.19-0251","article-title":"Two-Year Outcomes of Infants Enrolled in the First-in-Human Study of Amnion Cells for Bronchopulmonary Dysplasia","volume":"9","author":"Malhotra","year":"2020","journal-title":"Stem Cells Transl Med"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00549","article-title":"A Pilot Study Evaluating the Safety of Intravenously Administered Human Amnion Epithelial Cells for the Treatment of Hepatic Fibrosis","volume":"8","author":"Lim","year":"2017","journal-title":"Front Pharmacol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00198","article-title":"Phase 1 Trial of Amnion Cell Therapy for Ischemic Stroke","volume":"9","author":"Phan","year":"2018","journal-title":"Front Neurol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.642127\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T20:51:37Z","timestamp":1672951897000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.642127\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,29]]},"references-count":114,"alternative-id":["10.3389\/fimmu.2021.642127"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.642127","relation":{},"ISSN":["1664-3224"],"issn-type":[{"type":"electronic","value":"1664-3224"}],"subject":[],"published":{"date-parts":[[2021,7,29]]},"article-number":"642127"}}